← Eichor
Study identifier: NCT05705804 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

Condition: Dyslipidemias · Atherosclerotic Cardiovascular Disease  ·  Sponsor: Yonsei University

PhaseNA
Planned participants250
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The purpose of this study was to investigate the effect of pitavastatin or pitavastatin and ezetimibe combination therapy on glucose metabolism compared to atorvastatin in patients with atherosclerotic cardiovascular disease with metabolic syndrome.

This description comes directly from the study's public registry record.

Talk to the study team

Byeong-Keuk Kim  ·  82-2-2228-8465  ·  KIMBK@yuhs.ac

Always discuss trial participation with your own doctor first.

Locations (1)

Yonsei University Health System, Severance HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05705804